130 related articles for article (PubMed ID: 12757189)
21. Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users.
Tucker T; Fry CL; Lintzeris N; Baldwin S; Ritter A; Donath S; Whelan G
Addiction; 2004 Sep; 99(9):1157-66. PubMed ID: 15317636
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
[TBL] [Abstract][Full Text] [Related]
23. Validation of self-reported history of colorectal cancer screening.
Khoja S; McGregor SE; Hilsden RJ
Can Fam Physician; 2007 Jul; 53(7):1192-7. PubMed ID: 17872816
[TBL] [Abstract][Full Text] [Related]
24. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
25. Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population.
Hwang LY; Kramer JR; Troisi C; Bull L; Grimes CZ; Lyerla R; Alter MJ
Hepatology; 2006 Aug; 44(2):341-51. PubMed ID: 16871571
[TBL] [Abstract][Full Text] [Related]
26. An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users.
Spada E; Genovese D; Tosti ME; Mariano A; Cuccuini M; Proietti L; Giuli CD; Lavagna A; Crapa GE; Morace G; Taffon S; Mele A; Rezza G; Rapicetta M
J Hepatol; 2005 Dec; 43(6):958-64. PubMed ID: 16143420
[TBL] [Abstract][Full Text] [Related]
27. Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy "don't ask, draw a blood sample, vaccinate and try to schedule another visit".
de la Fuente L; Toro C; Brugal MT; Vallejo F; Soriano V; Barrio G; Ballesta R; Bravo MJ;
J Clin Virol; 2007 Jan; 38(1):87-90. PubMed ID: 17088099
[TBL] [Abstract][Full Text] [Related]
28. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
[TBL] [Abstract][Full Text] [Related]
29. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users.
Novelli LA; Sherman SG; Havens JR; Strathdee SA; Sapun M
Drug Alcohol Depend; 2005 Mar; 77(3):303-9. PubMed ID: 15734230
[TBL] [Abstract][Full Text] [Related]
30. Peer-delivered hepatitis C testing and counselling: a means of improving the health of injecting drug users.
Aitken CK; Kerger M; Crofts N
Drug Alcohol Rev; 2002 Mar; 21(1):33-7. PubMed ID: 12189002
[TBL] [Abstract][Full Text] [Related]
31. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
Judd A; Hickman M; Hope VD; Sutton AJ; Stimson GV; Ramsay ME; Gill ON; Parry JV
J Viral Hepat; 2007 Aug; 14(8):584-91. PubMed ID: 17650293
[TBL] [Abstract][Full Text] [Related]
32. [Risk factors for hepatitis C among injecting drug users in Oslo].
Dalgard O; Egeland A; Ervik R; Vilimas K; Skaug K; Steen TW
Tidsskr Nor Laegeforen; 2009 Jan; 129(2):101-4. PubMed ID: 19151801
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
[TBL] [Abstract][Full Text] [Related]
34. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
35. [Current situation and trends in the hepatitis C virus genotype distribution among injecting drug users in the Czech Republic].
Krekulová L; Rehák V; Strunecký O; Nēmecek V
Epidemiol Mikrobiol Imunol; 2009 Apr; 58(2):84-9. PubMed ID: 19526922
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Hepatitis B and C in the normal population and high risk groups in north Kerala.
Sandesh K; Varghese T; Harikumar R; Beena P; Sasidharan VP; Bindu CS; Tony J; Harish K; Sunilkumar K; Ramachandran TM
Trop Gastroenterol; 2006; 27(2):80-3. PubMed ID: 17089617
[TBL] [Abstract][Full Text] [Related]
37. Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports.
Wurst FM; Dürsteler-MacFarland KM; Auwaerter V; Ergovic S; Thon N; Yegles M; Halter C; Weinmann W; Wiesbeck GA
Alcohol Clin Exp Res; 2008 Sep; 32(9):1552-7. PubMed ID: 18616663
[TBL] [Abstract][Full Text] [Related]
38. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
Garfein RS; Swartzendruber A; Ouellet LJ; Kapadia F; Hudson SM; Thiede H; Strathdee SA; Williams IT; Bailey SL; Hagan H; Golub ET; Kerndt P; Hanson DL; Latka MH;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S4-17. PubMed ID: 17582705
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999.
Santibanez SS; Garfein RS; Swartzendruber A; Kerndt PR; Morse E; Ompad D; Strathdee S; Williams IT; Friedman SR; Ouellet LJ
Drug Alcohol Depend; 2005 Mar; 77(3):227-33. PubMed ID: 15734222
[TBL] [Abstract][Full Text] [Related]
40. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
